Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

L.G. van Baarsen, S. Vosslamber, M. Tijssen, J.M. Baggen, d., V van, J. Killestein, C.T.M. van der Pouw Kraan, C.H. Polman, C.L. Verweij

Research output: Contribution to journalArticleAcademicpeer-review

29 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)e1927
JournalPLoS ONE
Volume3
Issue number4
DOIs
Publication statusPublished - 2008

Cite this